FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-03 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2116-2 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0145-02 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-783-24 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 0143-9386-10 | Hikma Pharmaceuticals USA Inc. | NDA206968 | HUMAN PRESCRIPTION DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-02 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-09 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0145-89 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 52904-871-04 | Select Corporation | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-08 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2035-20 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-83 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 0264-4100-90 | B. Braun Medical Inc. | NDA204957 | HUMAN PRESCRIPTION DRUG | NDA |
ACETAMINOPHEN | 51672-2115-4 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-02 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2035-91 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 29485-8028-6 | Lil' Drug Store Products, Inc. | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 53808-0835-1 | State of Florida DOH Central Pharmacy | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-86 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51662-1424-1 | HF Acquisition Co LLC, DBA HealthFirst | NDA022450 | HUMAN PRESCRIPTION DRUG | NDA |
ACETAMINOPHEN | 51672-2114-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-09 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-94 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 52904-871-05 | Select Corporation | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 52904-871-25 | Select Corporation | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-33 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2116-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-309-02 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 0143-9386-01 | Hikma Pharmaceuticals USA Inc. | NDA206968 | HUMAN PRESCRIPTION DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 69168-285-37 | Allegiant Health | NDA020802 | HUMAN OTC DRUG | NDA |
-